Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly.
Influenza and pneumococcal vaccines are safe, effective, and cost-effective, but they are not used widely. Organized programs for vaccine delivery can lead to substantial improvements in vaccination rates for the elderly. Adequate reimbursement by Medicare and other third-party payers needs to be supplemented by educational programs to promote influenza and pneumococcal vaccines if the opportunity vaccination presents to improve the health and well-being of elderly persons is to be fully realized.
Fedson
D S
DS
Department of Medicine, University of Virginia School of Medicine, Charlottesville.
D000368:Aged; D001428:Bacterial Vaccines; D007722:Health Knowledge, Attitudes, Practice; D006291:Health Policy; D006299:Health Services for the Aged; D006760:Hospitalization; D006801:Humans; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000517:prevention & control; D011008:Pneumococcal Infections / Q000517:prevention & control; D013296:Streptococcus pneumoniae / Q000276:immunology*; D014481:United States; D014611:Vaccination / Q000191:economics / Q000523:psychology
D001428:Bacterial Vaccines; D007252:Influenza Vaccines